Simplex Trading, LLC Blueprint Medicines Corp Transaction History

Simplex Trading, LLC

  • $175 Billion
  • Q2 2025

A detailed history of Simplex Trading, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Simplex Trading, LLC holds 55,989 shares of BPMC stock, worth $7.25 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
55,989
Previous 4,704 1090.24%
Holding current value
$7.25 Million
Previous $416,000 1625.0%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 05, 2025
BUY
$79.22 - $128.4 $4.06 Million - $6.58 Million
51,285 Added 1090.24%
55,989 $7.18 Million
Q1 2025

May 12, 2025
SELL
$86.69 - $115.63 $165,057 - $220,159
-1,904 Reduced 28.81%
4,704 $416,000
Q4 2024

Feb 11, 2025
BUY
$82.48 - $101.39 $545,027 - $669,985
6,608 New
6,608 $576,000
Q2 2024

Jul 25, 2024
BUY
$85.18 - $108.78 $766 - $979
9 Added 0.33%
2,724 $293,000
Q1 2024

Apr 25, 2024
BUY
$73.17 - $99.79 $198,656 - $270,929
2,715 New
2,715 $257,000
Q3 2023

Nov 01, 2023
BUY
$46.9 - $66.0 $280,368 - $394,548
5,978 Added 41.16%
20,502 $1.03 Million
Q2 2023

Aug 04, 2023
BUY
$42.2 - $66.37 $600,674 - $944,710
14,234 Added 4908.28%
14,524 $917,000
Q1 2023

Apr 27, 2023
BUY
$37.97 - $50.0 $11,011 - $14,500
290 New
290 $13,000
Q2 2022

Aug 03, 2022
SELL
$45.23 - $70.15 $116,195 - $180,215
-2,569 Closed
0 $0
Q1 2022

May 02, 2022
BUY
$54.1 - $110.08 $109,173 - $222,141
2,018 Added 366.24%
2,569 $164,000
Q2 2021

Aug 12, 2021
BUY
$82.78 - $101.0 $45,611 - $55,651
551 New
551 $48,000
Q1 2021

Apr 26, 2021
SELL
$90.71 - $108.28 $46,080 - $55,006
-508 Closed
0 $0
Q4 2020

Feb 02, 2021
BUY
$92.08 - $124.48 $46,776 - $63,235
508 New
508 $0
Q2 2020

Jul 13, 2020
SELL
$57.09 - $79.27 $5,709 - $7,927
-100 Closed
0 $0
Q1 2020

Apr 29, 2020
BUY
$48.11 - $82.22 $4,811 - $8,222
100 New
100 $5,000
Q4 2019

Feb 05, 2020
SELL
$66.73 - $82.59 $146,672 - $181,532
-2,198 Closed
0 $0
Q3 2019

Oct 15, 2019
BUY
$72.9 - $101.41 $160,234 - $222,899
2,198 New
2,198 $161,000
Q3 2018

Oct 23, 2018
SELL
$58.91 - $78.32 $264,152 - $351,186
-4,484 Closed
0 $0
Q2 2018

Jul 30, 2018
BUY
$60.96 - $101.18 $273,344 - $453,691
4,484 New
4,484 $284,000
Q1 2018

Apr 26, 2018
SELL
$73.28 - $102.95 $94,091 - $132,187
-1,284 Closed
0 $0
Q4 2017

Jan 10, 2018
BUY
$62.91 - $88.32 $80,776 - $113,402
1,284
1,284 $96,000

Others Institutions Holding BPMC

# of Institutions
389
Shares Held
66.9M
Call Options Held
973K
Put Options Held
1.54M
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $7.73B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email